Predictors of medication adherence in patients with rheumatoid arthritis

Drug Development Research

Volumn 72, Issue 8, 2011, Pages 756-763

  Salt, Elizabeth ^a   Frazier, Susan K ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF NURSING   (United States)

Author keywords

medication adherence; predictors; rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ADULT; AGE; ARTICLE; DISEASE DURATION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; ETHNICITY; FEMALE; HEALTH DISPARITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PATIENT COMPLIANCE; RESIDENTIAL AREA; RHEUMATOID ARTHRITIS; SELF REPORT;

EID: 83655203338     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20484     Document Type: Article

References (31)

1. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. 2002. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 46: 328-346.
2. Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324. (Pubitemid 18091653)
3. Brus H, van de Laar M, Taal E, Rasker J, Wiegman O,. 1999. Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self efficacy expectations. Patient Educ Couns 36: 57-64. (Pubitemid 28535156)
4. Centers for Disease Control. 2007. Data and Statistics: national statistics: epidemiology briefs: rheumatoid arthritis. Retrieved November 3, 2007 (from).
5. Clatworthy J, Bowskill R, Parham R, Rank T, Scott J, Horne R,. 2009. Understanding medication nonadherence in bipolar disorders using a necessity-concerns framework. J Affect Disord 116: 51-55.
6. de Klerk E, van der Heijde D, Landewe R, van der Tempel H, Urquhart J, van der Linden S,. 2003. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica and gout. J Rheumatol 30: 44-54. (Pubitemid 36077771)
7. Doyle DV, Perrett D, Foster JF, Scotts DL,. 1993. The long-term use of D -penicillamine for treating rheumatoid arthritis: is continuous therapy necessary? Br J Rheumatol 32: 614-617. (Pubitemid 23224941)
8. Dunbar-Jacob J, Holmes JL, Sereika S, Kwoh CK, Burke LE, Starz TW, McCall M, Foley SM,. 2004. Factors associated with attrition of African-American during the recruitment phase of a clinical trial examining adherence among individuals with rheumatoid arthritis. Arthritis Rheum 51: 422-428. (Pubitemid 38725142)
9. Gabriel SE, Crowson CS, O'Fallon WM,. 1999. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum 42: 415-420. (Pubitemid 29136087)
10. Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB,. 2004. The concordance of self-reports with other measures of medication adherence. Med Care 42: 649-652.
11. Garcia-Gonzalez A, Richardson M, Popa-Lisseanu MG, Cox V, Kallen MA, Janssen N, Ng B, Marcus DM, Reveille JD, Suarez-Almazor ME,. 2008. Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 27: 883-889.
12. Hakala M, Nieminen P,. 1996. Functional status assessment of physical impairment in a community based population with rheumatoid arthritis: severely incapacitated patients are rare. J Rheumatol 23: 617-623. (Pubitemid 26139633)
13. Hakala M, Nieminen P, Koivisto O,. 1994. More evidence from a community-based series of better outcome in rheumatoid arthritis. Data on the effect of multidisciplinary care on the retention of functional ability. J Rheumatol 21: 1432-1437. (Pubitemid 24261524)
14. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, et al.; National Arthritis Data Workgroup 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Arthritis Rheum 58: 15-25.
15. Horne R, Weinman J,. 2002. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health 17: 17-32.
16. Lorish CD, Richards B, Brown S,. 1989. Missed medication doses in rheumatic arthritis patients: intentional and unintentional reasons. Arthritis Care Res 2: 3-9. (Pubitemid 19226079)
17. Lu CL, Williams KM, Day OR,. 2007. The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines. Aust NZ Health Policy 4: 1-11.
18. Maetzel A, Pencharz J, Tomlinson G, Bombardier C,. 2004. The economic burden associated with osteoarthritis, rheumatoid arthritis and hypertension: a comparative study. Ann Rheum Dis 63: 395-401. (Pubitemid 38453305)
19. Owen SG, Friesen WT, Roberts MS, Flux W,. 1985. Determinants of compliance in rheumatoid arthritis patients assessed in their home environment. Br J Rheum 24: 313-320. (Pubitemid 16250723)
20. Park DC, Hertzog C, Leventhal H, Morrell RW, Leventhal E, Birchmore D, Martin M, Bennett J,. 1999. Medication adherence in rheumatoid arthritis patients: older is wiser. J Am Geriatr Soc 47: 172-183. (Pubitemid 29082717)
21. Potter T, Mulherin D, Pugh M,. 2002. Early intervention with disease-modifying therapy for rheumatoid arthritis: where do the delays occur? Rheumatology 41: 953-955.
22. Saag KG, Doebbeling N, Rohrer JE, Kolluri S, Mitchell TA, Wallace RB,. 1998. Arthritis health service utilization among the elderly: the role of urban-rural residence and other utilization factors. Arthritis Care Res 11: 177-185. (Pubitemid 28306889)
23. Salt EG, Hall L, Peden AR, Horne R,. 2010. Psychometrics of medication adherence scales in patients with RA. Unpublished manuscript.
24. Taal E, Rasker JJ, Seydel ER, Weigman O,. 1993. Health status, adherence with health recommendations and social support in patients with rheumatoid arthritis. Patient Educ Couns 20: 68-76.
25. Treharne GJ, Lyons AC, Kitas GD,. 2004. Medication adherence in rheumatoid arthritis: effects of psychosocial factors. Psychol Health Med 9: 337-349. (Pubitemid 38988425)
26. Tuncay R, Eksioglu E, Cakir B, Gurcay E, Cakci A,. 2007. Factors affecting drug treatment compliance in patients with rheumatoid arthritis. Rheumatol Int 27: 743-746. (Pubitemid 46716729)
27. U.S. Department of Agriculture. 2010. Measuring rurality: rural-urban continuum codes ().
28. Viller F, Guillemin F, Briancon S, Moum T, Suurmeijer T, van der Heuvel W,. 1999. Compliance to drug treatment of patients with rheumatoid arthritis: a 3-year longitudinal study. J Rheumatol 26: 2114-2122. (Pubitemid 29487003)
29. Wang PP, Elsbett R, Geng G, Badley EM,. 2000. Arthritis prevalence and place of birth: findings from the 1994 Canadian National Population Health Survey. Am J Epidemiol 152: 425-442.
30. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA,. 1994. The mortality of rheumatoid arthritis. Arthritis Rheum 37: 481-494. (Pubitemid 24115934)
31. Wong M, Mulherin D,. 2007. The influence of medication beliefs and other psychosocial factors on early discontinuation of disease-modifying anti-rheumatic drugs. Musculoskeletal Care 5: 148-159.